BELLUS Health, Inc. (NASDAQ: BLUS), a global health company, is committed to developing and commercializing products that provide innovative health solutions to address substantial, but unmet needs. The company’s wholly owned subsidiary, OVOS Natural Health Inc., aims to develop a strong franchise with several products marketed to help brain function as well as expand to other conditions. For further information, visit the Company’s web site at www.bellushealth.com.
- 18 years ago
QualityStocks
BELLUS Health, Inc. (NASDAQ: BLUS)
Tags Rodman & Renshaw
Related Post
-
QualityStocksNewsBreaks – Regentis Biomaterials Ltd. (NYSE American: RGNT) Moves GelrinC Closer to Regulatory and Commercial Milestones
Regentis Biomaterials (NYSE American: RGNT) is advancing its GelrinC hydrogel-based cartilage regeneration technology toward key clinical, regulatory…
-
Wrap Technologies Inc. (NASDAQ: WRAP) Positions Non-Lethal Innovation at the Center of Public Safety Reform
WRAP offerings illustrate a broader industry trend toward building connected ecosystems rather than standalone products.…
-
Brownfield Gold Projects Could Hold an Edge in Today’s Permitting Environment
Disseminated on behalf of Lahontan Gold Corp. (TSX.V: LG) (OTCQB: LGCXF) and may include paid advertising.…